CliffBio
biologic

Daptacel

Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed

Loss of exclusivityMay 2014projected — 12-year biologic exclusivity estimate
CompanySanofi Vaccines Canada Ltd.

Drug detail

Brand nameDaptacel
Active ingredientDiphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed
Strength0.5ML
Dosage formInjection
RouteIntramuscular
ModalityBiologic
FDA approvalMay 2002
Marketing statusRx

More from Sanofi Vaccines Canada Ltd.

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Daptacel patent cliff — loss of exclusivity May 2014 | CliffBio